Frost & Sullivan releases the 'Blue Book on the Current Situation and Development Trends of the Global High-End Hyaluronic Acid Product Industry 2025' (with full text available for download)

Hyaluronic Acid (HA), also known as hyaluronate, is a linear polymer composed of D-glucuronic acid and N-acetylglucosamine connected alternately through β-1,3 and β-1,4 glycosidic bonds.polysaccharide compoundIts molecular weight range is extensive, ranging from several thousand to several million daltons (Da).

The physiological function of hyaluronic acid is closely related to its molecular weight. LargeMolecular weight hyaluronic acid(HMW-HA) has the functions of lubricating joints, protecting cartilage, antioxidation, and maintaining the structure of extracellular matrix. It is commonly used in the treatment of osteoarthritis and minor eye surgeries (such as cataracts). Low molecular weight hyaluronic acid (LMW-HA) can promote wound healing, angiogenesis, and immune regulation, and is used in functional skincare products and wound repair products.

According to molecular weight, cross-linking process, and application field, hyaluronic acid can be classified differently. For instance, based on molecular weight, hyaluronic acid is divided into large molecule hyaluronic acid, medium molecule hyaluronic acid, and small molecule hyaluronic acid; according to different cross-linking techniques, hyaluronic acid can be categorized into single-phase hyaluronic acid anddiphasicHyaluronic acid; Depending on the application field, hyaluronic acid can be divided into pharmaceutical grade, cosmetic grade, and food grade, etc.

Pure hyaluronic acid often requires a series of treatments to be more widely applied due to its solubility in water, rapid absorption, short retention time in tissues, and poor mechanical properties. In the field of medical aesthetics injection products, the most common modification is cross-linking. Depending on the state of cross-linking, hyaluronic acid fillers are commonly classified as 'monophasic' and 'biphasic'. Monophasic refers to materials with uniform chemical composition and physical state, while biphasic refers to materials with two or more different chemical compositions or non-uniform physical states.

As a revolutionary biomaterial, hyaluronic acid has evolved from a laboratory discovery in 1934 into an important global industry. Although China started relatively late, it has rapidly risen to become the world's largest producer and exporter of hyaluronic acid raw materials due to technological breakthroughs in microbial fermentation.

Source: Analysis by Frost & Sullivan

The industrial preparation of hyaluronic acid mainly adopts the microbial fermentation method. This method typically uses glucose as a carbon source, utilizing specific strains to produce hyaluronic acid in fermentation tanks. Subsequently, the final product is made through a series of steps including cross-linking, purification, filling, and sterilization. To reduce production costs and implement sustainable development concepts, the industry has also begun exploring the use of agricultural waste as fermentation substrates.

In the preparation process of hyaluronic acid, cross-linking technology plays a crucial role. Natural hyaluronic acid is rapidly degraded in the body and cannot meet the long-term needs of medical aesthetic fillings. By connecting natural hyaluronic acid molecular chains into a stable three-dimensional network structure with cross-linking agents, it has been successfully transformed into a medical aesthetic material capable of long-term shaping. Cross-linking technology directly determines the product's support strength, cohesion, anti-degradation ability, and duration of retention in the body. It is a core technical barrier that differentiates high-end from ordinary products and has become the cornerstone for brands to build their product moats.

Source: Analysis by Frost & Sullivan

The 'Blue Book' sorts out the definition and classification of hyaluronic acid, the global and Chinese development history of hyaluronic acid, hyaluronic acid preparation methods and cross-linking technology, the characteristics and advantages of hyaluronic acid applications in the medical aesthetics field, etc. For more detailed content, please refer to the full report.

The current Chinese hyaluronic acid market has passed the 'existence or non-existence' phase and is undergoing a profound transformation from 'extensive filling' to 'precise sculpting'. Driven by both technological progress and the upgrading of consumer awareness, the market is significantly developing towards higher-end and more refined directions. This is not only a higher requirement for product efficacy but also indicates the core competitive direction for the future in the medical aesthetics injection field.

High-end hyaluronic acid products are an inevitable result of market and demand development. Their value pursuit has gone beyond mere 'filling' to achieve superior biocompatibility, durability, and safety. The aim is to meet consumers' ultimate anti-aging and beauty enhancement goals in different facial areas through refined applications.

High-end hyaluronic acid products have higher compliance and safety requirements compared to mid- to low-end ones. The products themselves possess more unique physical and chemical properties and technical barriers, which can meet consumers' more precise indication needs, offer superior clinical effects and persistence, and at the same time, consumers have a higher recognition of brands.

Source: Analysis by Frost & Sullivan

●Joyard

Juvéderm is the flagship hyaluronic acid brand of Elji. As a global market leader, Juvéderm entered China many years ago and established its benchmark position in the high-end market. Its brand positioning is 'luxury, efficiency, and durability', attracting consumers with extremely high standards for medical aesthetics through its excellent shaping effects and long-lasting maintenance time.

Erjian has built a mid-to-high-end hyaluronic acid product brand by creating a full range of products under the Jo brand. Its high-end hyaluronic acid products such as Fengyan and Tiyan focus on facial contour enhancement, deep tissue filling, and dynamic facial filling and modification, enjoying high recognition and brand awareness within the industry.

Source: Public information, analysis by Frost & Sullivan

● Rui Lan

GaodemeiThe Restylane series under Galderma enjoys a high reputation worldwide. In 1996, Restylane became the world's first approved stable hyaluronic acid filler for marketing and was also the first 'non-animal-derived' stable hyaluronic acid filler. It avoided potential allergic risks and batch differences that could arise from extracting from animal tissues, greatly enhancing product safety and consistency, and laying a solid foundation for the widespread application of hyaluronic acid in the medical aesthetics field.

After decades of development, the Ruilan brand has also developed a rich product portfolio based on its brand technology, which can be applied to a variety of different indications, including the nose, chin, midface, lower jawline, nasolabial folds, etc., to meet the consumption needs of different consumer groups.

Source: Public information, analysis by Frost & Sullivan

●Seawitch

In 2013, Huarui, a hyaluronic acid brand under Shanghai Haohai Biotechnology Co., Ltd. (collectively referred to as 'Haohai Bio')^®Approved for listing, 2017 Jiao Lan^®Approved for listing, along with the overall enhancement of the brand and technical strength, in 2020, it launched its high-end hyaluronic acid product, Haimei^®The launch has formed a complete hyaluronic acid brand product line of Haohai Bio-Tech, complementing previous products and covering the markets for low, medium, and high-end hyaluronic acid products.

Seabird^®It is a high-end sodium hyaluronate gel product for injection. As the third-generation hyaluronic acid product from Haohai Bio-Tech, it adopts linear cross-linking technology. This technology aims to transform the natural disordered structure of hyaluronic acid into an ordered linear structure through molecular rearrangement. As a result, the prepared hyaluronic acid gel becomes a uniform and viscous fluid without particles, offering multiple clinical advantages. At the market level, Haimei^®The launch is seen as a response to the high-end hyaluronic acid market dominated by imported brands. Its market positioning is high-end hyaluronic acid, aiming to enter the market with quality comparable to international brands and at a relatively more affordable price. With its unique product characteristics, Haimei^®The company has gained recognition for its positioning as a high-end hyaluronic acid provider in the market, contributing significantly to the revenue of Haohai Shengke Medical Beauty's hyaluronic acid product line.

2024Seahorn Moon WhiteApproved for market launch, it adopts the world's first amino acid cross-linking technology, becoming an important product series of Haohai Bio's high-end hyaluronic acid brand. It is expected to bring new growth points to the high-end hyaluronic acid product market.

Source: Public information, analysis by Frost & Sullivan

●Seabird Moon White

Haimei Moon White is a hyaluronic acid (ACHA) product innovatively cross-linked with amino acids by Haohai Bioengineering. In this process, the carboxyl group of HA can undergo an amidation reaction with the amino group of lysine to form an aminoamide, resulting in non-toxic cross-linking HA. This not only extends the product's shelf life but also endows Haimei Moon White with the characteristic of stimulating collagen regeneration. Its effect has been confirmed through a series of re-aging experiments, indicating its anti-aging properties.

Source: Public information, analysis by Frost & Sullivan

The 'Blue Book' summarizes the representative brands and products of high-end hyaluronic acid listed in China, analyzing their brand overview and market positioning, product matrix and pricing strategy, core technical advantages, clinical effectiveness and market performance, etc. For more detailed content, please refer to the full report.

The global hyaluronic acid industry is entering a period of profound adjustment, facing multiple challenges including continuous pressure on the price system and profit structure, market diversion due to the accelerated emergence of new renewable materials, and rising compliance costs caused by stricter domestic and international regulatory policies.

In this industry's changing landscape, advanced cross-linking processes with independent intellectual property rights have gone beyond basic production stages, becoming the key technical anchor determining product performance differences and brand value. They are also a solid moat for enterprises to build their core competitiveness. At the same time, the application boundaries of hyaluronic acid are continuously expanding, and its therapeutic value in medical fields such as orthopedics, ophthalmology, and gynecology is becoming increasingly prominent, with market demand continuously being released. In the booming field of medical aesthetics, as consumers' understanding of professional medical aesthetics deepens, the consumer group has expanded from a single female audience to a wider age range and gender, making the market foundation increasingly solid.

Looking ahead, the strategic vision of domestic hyaluronic acid leaders has comprehensively upgraded - no longer content with merely playing the role of a 'raw material supplier' in the global industrial chain. Instead, they are firmly climbing up the value chain, committed to creating high-end brands with both international reputation and product strength through the dual-wheel drive of 'technology + brand', and driving China's smart manufacturing to achieve a historic leap from 'following behind' to 'running alongside' and even 'leading' in the global high-end medical beauty market.

The 'Blue Book' comprehensively analyzes the challenges and trends in the global hyaluronic acid field, and examines the strategic planning of leading companies that complements their technological evolution with brand building. For more detailed content, please refer to the full report.

The report concludes by analyzing the capital dynamics in the hyaluronic acid field, pointing out that industry mergers and acquisitions have evolved from acquiring single products to building comprehensive ecological platforms that cover hyaluronic acid, botulinum toxin, regenerative materials, and optoelectronic equipment. The support from the capital market is particularly crucial. Chinese companies such as Haohai Shengke practice the 'A+H' dual-platform listing to broaden financing channels and promote international strategies, while international giants strengthen their leadership through large-scale mergers and acquisitions, indicating that industry competition has entered a new stage of competition across the entire industrial chain and ecological niche.

Source: Public information, analysis by Frost & Sullivan

The 'Blue Book' sorts out the capital market dynamics and trends in the hyaluronic acid field, including mergers and acquisitions, investment and financing, and listings. For more detailed content, please refer to the full report.